A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma.
Khorana A, Bunn P, McLaughlin P, Vose J, Stewart C, Czuczman MS. A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma. Leuk Lymphoma. 2001 Mar; 41(1-2):77-87.
-
Adult
-
Aged
-
Alemtuzumab
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm
-
Antigens, CD
-
Antigens, Neoplasm
-
Antineoplastic Agents
-
Bacterial Infections
-
CD52 Antigen
-
Disease-Free Survival
-
Dose-Response Relationship, Drug
-
Follow-Up Studies
-
Glycoproteins
-
Humans
-
Immunization, Passive
-
Immunophenotyping
-
Lymphoma, Non-Hodgkin
-
Middle Aged
-
Neoplasm, Residual
-
Treatment Outcome